title: Debate on long-acting β agonists for asthma: they think it's all over.
authors.affiliation: Scottish Centre for Respiratory Research, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UK. Electronic address: b.j.lipworth@dundee.ac.uk.
authors.forename: Brian
authors.initials: B
authors.lastname: Lipworth
authors.affiliation: Scottish Centre for Respiratory Research, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UK.
authors.forename: Sunny
authors.initials: S
authors.lastname: Jabbal
mesh_terms: D000280:Administration, Inhalation; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D000069502:Budesonide, Formoterol Fumarate Drug Combination / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D004305:Dose-Response Relationship, Drug; D000068297:Fluticasone-Salmeterol Drug Combination / Q000627:therapeutic use*; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D009330:Nebulizers and Vaporizers; D016896:Treatment Outcome
chemical_list: D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D000069502:Budesonide, Formoterol Fumarate Drug Combination; D003692:Delayed-Action Preparations; D000068297:Fluticasone-Salmeterol Drug Combination; D005938:Glucocorticoids